| Identification | Back Directory | [Name]
N4-Banzoyl-5-methyl-2'-O,4'-C-methylenecytidine | [CAS]
206055-81-4 | [Synonyms]
LNA-N4-Bz-methyl-C
N-benzoyl-5-methyl-2'-O,4'-C-methylene-Cytidine
N4-Benzoyl-5-methyl-2’-O,4’-C-methylenecytidine
N4-Banzoyl-5-methyl-2'-O,4'-C-methylenecytidine
(1S,3R,4R,7S)-7-hydroxy-1-hydroxymethyl-3-(5-methyl-4-N-benzoylcytosine-1-yl)-2,5-dioxabicyclo[2.2.1]heptane | [Molecular Formula]
C18H19N3O6 | [MDL Number]
MFCD32215160 | [MOL File]
206055-81-4.mol | [Molecular Weight]
373.37 |
| Hazard Information | Back Directory | [Uses]
N4-Benzoyl-5-methyl-2’-O,4’-C-methylenecytidine is a cytidine analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities[1]. | [References]
[1] Gowher H, et al. Mechanism of inhibition of DNA methyltransferases by cytidine analogs in cancer therapy. Cancer Biol Ther. 2004 Nov;3(11):1062-8. DOI:10.4161/cbt.3.11.1308 |
|
| Company Name: |
NewCan Biotech Limited
|
| Tel: |
+86-0571-86912261 +86-15658003402 |
| Website: |
https://www.newcanbio.com/ |
|